Literature DB >> 8612745

Antibacterial activity of peptides homologous to a loop region in human lactoferrin.

E W Odell1, R Sarra, M Foxworthy, D S Chapple, R W Evans.   

Abstract

Human lactoferrin contains a 46 residue sequence named lactoferricin H thought to be responsible for its antimicrobial properties. Synthetic peptides HLT1, corresponding to the loop region of human lactoferricin (FQWQR-NMRKVRGPPVS) and HLT2, corresponding to its charged portion (FQWQRNMRKVR), exerted significant antibacterial effects against E. coli serotype O111 strains NCTC 8007 and ML35. The corresponding sequences in native human lactoferrin were shown to adopt a charged helix and hydrophobic tail within the N-lobe remote from the iron binding site. Sequence similarities between lactoferricin and dermaseptin and magainins suggest that lactoferricin may act as an amphipathic alpha helix.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8612745     DOI: 10.1016/0014-5793(96)00168-8

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  22 in total

1.  N-Acylated and D enantiomer derivatives of a nonamer core peptide of lactoferricin B showing improved antimicrobial activity.

Authors:  H Wakabayashi; H Matsumoto; K Hashimoto; S Teraguchi; M Takase; H Hayasawa
Journal:  Antimicrob Agents Chemother       Date:  1999-05       Impact factor: 5.191

Review 2.  Peptide antibiotics.

Authors:  R E Hancock; D S Chapple
Journal:  Antimicrob Agents Chemother       Date:  1999-06       Impact factor: 5.191

3.  Lactoferrin-lipid A-lipopolysaccharide interaction: inhibition by anti-human lactoferrin monoclonal antibody AGM 10.14.

Authors:  D Caccavo; A Afeltra; S Pece; G Giuliani; M Freudenberg; C Galanos; E Jirillo
Journal:  Infect Immun       Date:  1999-09       Impact factor: 3.441

4.  Production of stable isotope enriched antimicrobial peptides in Escherichia coli: an application to the production of a 15N-enriched fragment of lactoferrin.

Authors:  A Majerle; J Kidric; R Jerala
Journal:  J Biomol NMR       Date:  2000-10       Impact factor: 2.835

5.  Structure-function relationship of antibacterial synthetic peptides homologous to a helical surface region on human lactoferrin against Escherichia coli serotype O111.

Authors:  D S Chapple; D J Mason; C L Joannou; E W Odell; V Gant; R W Evans
Journal:  Infect Immun       Date:  1998-06       Impact factor: 3.441

Review 6.  Lactoferrin: A Roadmap to the Borderland between Caries and Periodontal Disease.

Authors:  D H Fine
Journal:  J Dent Res       Date:  2015-03-17       Impact factor: 6.116

7.  N-linked glycosylation at Asn3 and the positively charged residues within the amino-terminal domain of the c1 inhibitor are required for interaction of the C1 Inhibitor with Salmonella enterica serovar typhimurium lipopolysaccharide and lipid A.

Authors:  Dongxu Liu; Cort C Cramer; Jennifer Scafidi; Alvin E Davis
Journal:  Infect Immun       Date:  2005-08       Impact factor: 3.441

8.  One of two human lactoferrin variants exhibits increased antibacterial and transcriptional activation activities and is associated with localized juvenile periodontitis.

Authors:  Kabilan Velliyagounder; Jeffrey B Kaplan; David Furgang; Diana Legarda; Gill Diamond; Ruth E Parkin; Daniel H Fine
Journal:  Infect Immun       Date:  2003-11       Impact factor: 3.441

9.  Structure and association of human lactoferrin peptides with Escherichia coli lipopolysaccharide.

Authors:  Daniel S Chapple; Rohanah Hussain; Christopher L Joannou; Robert E W Hancock; Edward Odell; Robert W Evans; Giuliano Siligardi
Journal:  Antimicrob Agents Chemother       Date:  2004-06       Impact factor: 5.191

10.  Structure-microbicidal activity relationship of synthetic fragments derived from the antibacterial alpha-helix of human lactoferrin.

Authors:  L Håversen; N Kondori; L Baltzer; L A Hanson; G T Dolphin; K Dunér; I Mattsby-Baltzer
Journal:  Antimicrob Agents Chemother       Date:  2009-11-16       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.